Patent details

Basic Information

Publication number:

EP2288727

PCT Application Number:

PCT/US/2009/043823

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP097474928

PCT Publication Number:

WO/2009/140409

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PREDICTORS OF PATIENT RESPONSE TO TREATMENT WITH EGF RECEPTOR INHIBITORS

French Title of Invention:

PRÉDICTEURS DE RÉPONSE DE PATIENT À UN TRAITEMENT AVEC DES INHIBITEURS DES RÉCEPTEURS DE EGF

German Title of Invention:

VORHERSAGEINDIKATOREN DES ANSPRECHENS VON PATIENTEN AUF EINE BEHANDLUNG MIT EGF-REZEPTOR-INHIBITOREN

SPC Number:

Dates

Filing date:

13/05/2009

Grant date:

10/07/2013

EP Publication Date:

10/07/2013

PCT Publication Date:

19/11/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

02/03/2011

EP B1 Publication Date:

10/07/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

13/05/2014

Expiration date:

13/05/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

13/05/2009

 

 

Name:

Bristol-Myers Squibb Company

Address:

Route 206 & Province Line Road, Princeton, NJ 08543, United States (US)

Name:

Genomic Health Inc.

Address:

301 Penobscot Drive, Redwood City, CA 94063, United States (US)

Inventor

1

Name:

FORD Shirin, K.

Address:

United States (US)

2

Name:

SHAK Steven

Address:

United States (US)

3

Name:

WATSON Drew

Address:

United States (US)

4

Name:

MADDALA Tara

Address:

United States (US)

5

Name:

BAKER Joffre, B.

Address:

United States (US)

6

Name:

MAURO David, J.

Address:

United States (US)

Priority

Priority Number:

127816 P

Priority Date:

14/05/2008

Priority Country:

United States (US)

Classification

Main IPC Class:

C12Q 1/68;

Filing date	Document type	Number of pages